The CEO of French consumer goods giant Danone on Wednesday downplayed the threat of obesity drugs on its food business. Antoine de Saint-Affrique told CNBC that surging demand for drugs like Wegovy ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Stymied in its takeover bid for Lifeway Foods, minority ...
Danone has signed an agreement to sell its Swedish probiotic fruit juices brand ProViva to fellow dairy peer Lactalis for an undisclosed sum. The deal, signed with ProViva’s minority owner, dairy ...
Reflecting its earnings and cash-flow progress, Danone’s board will propose a dividend of EUR 2.25 per share, an increase of about 5% year-on-year. The payout rise roughly tracks EPS growth, ...
Danone and Nutri-Score’s relationship wasn’t always sour. When the nutrition labelling scheme first entered the market, Danone was among the first adopters. Soon, Danone was rallying for the mandatory ...
Divestitures in Q1-2024 indicate that management continues to execute its “Renew Danone” plan, with a primary focus still on internal reorganization. Net income has been battered by extraordinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results